Combination of mesenchymal stem cells and FK506 prolongs heart allograft survival by inhibiting TBK1/IRF3-regulated-IFN-γ production

This publication has 35 references indexed in Scilit:

• Donor-Derived Mesenchymal Stem Cells Combined With Low-Dose Tacrolimus Prevent Acute Rejection After Renal Transplantation
  Transplantation, 2013
• Double negative Treg cells promote nonmyeloablative bone marrow chimerism by inducing T‐cell clonal deletion and suppressing NK cell function
  European Journal of Immunology, 2012
• Bone Marrow–Derived Mesenchymal Stem Cells as Immunosuppressants in Liver Transplantation: A Review of Current Data
  Transfusion Medicine Reviews, 2011
• Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model
  Transplant Immunology, 2011
• Glycogen Synthase Kinase 3β Regulates IRF3 Transcription Factor-Mediated Antiviral Response via Activation of the Kinase TBK1
  Immunity, 2010
• Immunity, Inflammation, and Cancer
  Cell, 2010
• Infusion of Mesenchymal Stem Cells and Rapamycin Synergize to Attenuate Alloimmune Responses and Promote Cardiac Allograft Tolerance
  American Journal of Transplantation, 2009
• Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate
  Transplant Immunology, 2008
• Mesenchymal stem cells might be used to induce tolerance in heart transplantation
  Medical Hypotheses, 2007
• Immunologic properties of human fetal mesenchymal stem cells
  American Journal of Obstetrics and Gynecology, 2004